Eli Lilly and Co Analyst Ratings

Benzinga12:25

Jefferies Maintains Buy on Eli Lilly and Co, Raises Price Target to $957

Benzinga12:26

Halozyme Downgraded at Piper Sandler Despite Guidance Raise

Seeking AlphaJun 7 08:16

Citigroup Adjusts Price Target on Johnson & Johnson to $180 From $185, Keeps Buy Rating

MT NewswiresJun 6 04:16

HSBC Adjusts Price Target on Merck & Co. to $130 From $118, Keeps Hold Rating

MT NewswiresJun 5 05:22

AbbVie Analyst Ratings

BenzingaJun 5 05:06

HSBC Upgrades AbbVie to Buy, Announces $185 Price Target

BenzingaJun 5 05:17

Merck & Co Analyst Ratings

BenzingaJun 4 12:25

Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $155 Price Target

BenzingaJun 4 12:26

Johnson & Johnson Analyst Ratings

BenzingaJun 4 08:54

Abbott Laboratories Analyst Ratings

BenzingaJun 4 08:34

RBC Capital Reiterates Outperform on Abbott Laboratories, Maintains $125 Price Target

BenzingaJun 4 08:35

Thermo Fisher Scientific Analyst Ratings

BenzingaJun 3 08:06

Jefferies Assumes Thermo Fisher Scientific at Buy, Raises Price Target to $650

BenzingaJun 3 08:08

Thermo Fisher Scientific: Jefferies assumes buying and holding ratings; target share price is $650 to $600

Zhitong FinanceJun 3 00:59

Strong Financial Outlook and Strategic Initiatives Underpin Buy Rating for AbbVie

TipRanksJun 2 20:15

Changes in US stocks 丨 UnitedHealth bucked the trend and rose 2.5%, getting Xiaoma to raise the target price

Gelonghui FinanceMay 31 11:18

Abbott: Goldman Sachs starts reporting with a buy rating; target share price is $121

Zhitong FinanceMay 31 04:17

Eli Lilly: Goldman Sachs raised the target price from $740 to $785

Zhitong FinanceMay 31 03:43

Wells Fargo Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

TipRanksMay 30 22:04